Location History:
- Osaka, JP (1981 - 1982)
- Kobe, JP (1993 - 1994)
Company Filing History:
Years Active: 1981-1994
Title: Innovations of Seiichi Iwamoto
Introduction
Seiichi Iwamoto is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to his name, Iwamoto's work has had a profound impact on medical diagnostics.
Latest Patents
Iwamoto's latest patents include groundbreaking innovations such as anti-procollagenase monoclonal antibodies. He has also developed a method for the assay of anti-human papillomavirus monoclonal antibodies. One of his notable inventions is an anti-human papillomavirus (HPV) monoclonal antibody that is reactive with various types of HPVs. This antibody is produced by a hybridoma that comprises a fused cell of a mouse spleen cell from a mouse immunized with an alkali-treated HPV type 1 (HPV-1) and a mouse myeloma cell. It is reactive with polypeptides of approximately 57 kilodaltons, 160 kilodaltons, and 230 kilodaltons of HPV-1. This monoclonal antibody is particularly useful for the diagnosis of various types of HPV infections.
Career Highlights
Seiichi Iwamoto is currently associated with Kanebo, Limited, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the understanding and treatment of HPV-related conditions.
Collaborations
Iwamoto has collaborated with esteemed colleagues such as Shintaro Inoue and Hiroshi Ohmoto. Their combined expertise has contributed to the success of their research and development efforts.
Conclusion
Seiichi Iwamoto's contributions to the field of biotechnology, particularly in the area of monoclonal antibodies, highlight his role as a leading inventor. His innovative work continues to pave the way for advancements in medical diagnostics and treatment.